Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US8292141053
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG000BS2ZD1
SLP

Simulations Plus Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Health Information Services · THEMEFOLIO: $HLTH
NAME
Simulations Plus Inc
ISIN
US8292141053
TICKER
SLP
MIC
XNAS
REUTERS
SLP.OQ
BLOOMBERG
SLP US
Wed, 30.10.2024       Simulations Plus

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced a newly funded grant from the U.S. Food and Drug Administration (FDA), secured in partnership with the University of Strathc...
Wed, 23.10.2024       Simulations Plus

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its fourth quarter and fiscal 2024, ended August 31, 2024. Fourth Quarter 2024 Financial Highlights (c...
Wed, 09.10.2024       Simulations Plus

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), announced today that it will report fourth quarter and fiscal 2024 financial results after the market close on Wednesday, October 23, 2024. Management will host a conference call that same day at 5:00 p.m. Eastern Time to discuss the results. Investment professionals and all current and p...
Tue, 08.10.2024       Simulations Plus

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced the award of a new research grant from the National Institutes of Health (NIH), secured in partnership with the University o...
Wed, 28.08.2024       Simulations Plus

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications for the biopharma industry, today announced that Shawn O’Connor, chief executive officer, will participate in the Morgan Stanley 22nd Annual Global Healthcare Conferen...
Fri, 23.08.2024       Simulations Plus

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications for the biopharma industry, today announced the optimization of its business unit and leadership structure to support future growth following the Company’s recent acqu...
Tue, 12.01.2021       Simulations Plus

New York, New York--(Newsfile Corp. - January 12, 2021) -  Levi & Korsinsky announces it has commenced an investigation of Simulations Plus, Inc. (NASDAQ: SLP) concerning possible breaches of fiduciary duty. To obtain additional information, go to:https://www.zlk.com/compensation2/simulations-plus-inc-information-request-formor contact Jos...